Atreca (BCEL) Short Interest Ratio & Short Volume → A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad) Free BCEL Stock Alerts $0.09 0.00 (-4.25%) (As of 05:39 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Atreca Short Interest DataCurrent Short Volume148,000 sharesPrevious Short Volume272,700 sharesChange Vs. Previous Month-45.73%Dollar Volume Sold Short$25,160.00Short Interest Ratio / Days to Cover0.0Last Record DateMarch 15, 2024Outstanding Shares39,620,000 sharesPercentage of Shares Shorted0.37%Today's Trading Volume333,302 sharesAverage Trading Volume5,557,481 sharesToday's Volume Vs. Average6% Short Selling Atreca ? Sign up to receive the latest short interest report for Atreca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBCEL Short Interest Over TimeBCEL Days to Cover Over TimeBCEL Percentage of Float Shorted Over Time Ad Weiss RatingsTiny AI projects with huge promise hiding in plain sight …I’ve developed a system that’s helped me find huge winners in the past. Now my system has alerted me to the next four altcoins that could be the next superstars.Click here to find out who they are. Atreca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024148,000 shares $25,160.00 -45.7%N/A0 $0.17 2/29/2024272,700 shares $70,902.00 -89.6%N/A0 $0.26 2/15/20242,630,000 shares $828,450.00 -32.7%9.0%0.3 $0.32 1/31/20243,910,000 shares $1.15 million +18.1%13.3%0.5 $0.29 1/15/20243,310,000 shares $1.18 million +7.8%11.3%0.4 $0.36 12/31/20233,070,000 shares $405,240.00 +20.4%10.5%1.3 $0.13 Get the Latest News and Ratings for BCEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atreca and its competitors with MarketBeat's FREE daily newsletter. 12/15/20232,550,000 shares $688,500.00 -4.1%8.7%1.1 $0.27 11/30/20232,660,000 shares $584,402.00 -11.0%9.1%1.3 $0.22 11/15/20232,990,000 shares $599,196.00 -28.1%10.2%1.6 $0.20 10/31/20234,160,000 shares $873,600.00 +42.0%14.4%2.2 $0.21 10/15/20232,930,000 shares $966,900.00 +6.9%10.1%1.6 $0.33 9/30/20232,740,000 shares $715,140.00 +0.7%9.5%13 $0.26 9/15/20232,720,000 shares $952,000.00 -2.5%9.4%13.7 $0.35 8/31/20232,790,000 shares $1.03 million +0.4%9.6%13.9 $0.37 8/15/20232,780,000 shares $1.20 million +14.9%9.6%14.9 $0.43 7/31/20232,420,000 shares $2.34 million -2.8%8.5%20.2 $0.97 7/15/20232,490,000 shares $2.42 million -0.4%8.7%23.4 $0.97 6/30/20232,500,000 shares $2.45 million +2.0%8.8%22.6 $0.98 6/15/20232,450,000 shares $2.89 million -2.4%8.6%20 $1.18 5/31/20232,510,000 shares $2.51 million -3.8%8.8%21.3 $1.00 5/15/20232,610,000 shares $2.79 million No Change9.1%20.4 $1.07 4/30/20232,610,000 shares $2.61 million +3.6%9.1%20.3 $1.00 4/15/20232,520,000 shares $2.34 million -1.2%8.8%17.5 $0.93 3/31/20232,550,000 shares $2.91 million +2.8%8.9%15.1 $1.14 3/15/20232,480,000 shares $3.30 million +0.8%8.6%15.2 $1.33 2/28/20232,460,000 shares $3.52 million -2.0%8.6%13.7 $1.43 2/15/20232,510,000 shares $4.32 million +2.5%8.8%14.4 $1.72 1/31/20232,450,000 shares $4.12 million -0.4%8.5%13.3 $1.68 1/15/20232,460,000 shares $4.01 million +2.1%8.6%14.3 $1.63 12/30/20222,410,000 shares $1.93 million -1.6%8.4%15.1 $0.80 12/15/20222,450,000 shares $2.57 million -0.4%8.5%18.5 $1.05 11/30/20222,460,000 shares $2.63 million -0.4%8.6%19.5 $1.07 11/15/20222,470,000 shares $3.75 million -5.4%8.6%21.3 $1.52 10/31/20222,610,000 shares $3.78 million -1.5%9.2%23 $1.45 10/15/20222,650,000 shares $3.92 million -2.2%9.4%22.1 $1.48 9/30/20222,710,000 shares $4.25 million +1.5%9.6%19.6 $1.57 9/15/20222,670,000 shares $5.69 million +1.5%9.4%12.5 $2.13 8/31/20222,630,000 shares $4.89 million -3.7%9.3%11.2 $1.86 8/15/20222,730,000 shares $7.48 million -7.8%9.7%9.9 $2.74 7/31/20222,960,000 shares $5.83 million +1.7%10.5%10 $1.97A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. BCEL Short Interest - Frequently Asked Questions What is Atreca's current short interest? Short interest is the volume of Atreca shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 148,000 shares of BCEL short. Learn More on Atreca's current short interest. Is Atreca's short interest increasing or decreasing? Atreca saw a decrease in short interest in March. As of March 15th, there was short interest totaling 148,000 shares, a decrease of 45.7% from the previous total of 272,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Atreca's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Atreca: GeoVax Labs, Inc. (0.32%), Evoke Pharma, Inc. (0.56%), ZyVersa Therapeutics, Inc. (2.08%), Seelos Therapeutics, Inc. (6.86%), Longeveron Inc. (3.56%), Soligenix, Inc. (6.22%), Ensysce Biosciences, Inc. (0.14%), Petros Pharmaceuticals, Inc. (3.25%), Cyclacel Pharmaceuticals, Inc. (29.26%), Phio Pharmaceuticals Corp. (4.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Atreca stock? Short selling BCEL is an investing strategy that aims to generate trading profit from Atreca as its price is falling. BCEL shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atreca? A short squeeze for Atreca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCEL, which in turn drives the price of the stock up even further. How often is Atreca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCEL, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: GOVX Short Interest EVOK Short Interest ZVSA Short Interest SEEL Short Interest LGVN Short Interest SNGX Short Interest ENSC Short Interest PTPI Short Interest CYCC Short Interest PHIO Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCEL) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetry